
    
      This is a randomized study aimed at evaluating in 60 patients with either acute coronary
      syndromes or stable coronary artery disease submitted with PCI and stenting, endothelization
      and malapposition at 6 months follow-up (primary endpoint), evaluated by means of optical
      coherence tomography in terms of number of struts not re-endothelized or malapposed, after
      the implantation of three new generation stent: Cre8, Biomatrix and Xience. Further clinical
      follow-up will be performed to evaluate MACE at 12 months follow-up.
    
  